Modulation of postsynaptic potentials in rat cortical neurons by valerian extracts macerated with different alcohols: Involvement of adenosine A 1- and GABAA-receptors

Phytotherapy Research

Volumn 21, Issue 10, 2007, Pages 932-937

  Sichardt, K ^a   Vissiennon, Z ^a   Koetter, U ^b   Brattstrom A ^b   Nieber, Karen ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Max Zeller Sohne AG   (Switzerland)

Author keywords

Adenosine A1 receptor; Cortex; GABAA receptor; Postsynaptic potential; Pyramidal cells; Valerian extracts

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ACETIC ACID ETHYL ESTER; ADENOSINE A1 RECEPTOR; ALCOHOL; METHANOL; PICROTOXIN; VALERIAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN SLICE; CINGULATE GYRUS; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG ISOLATION; DRUG MECHANISM; ELECTROSTIMULATION; NONHUMAN; POSTSYNAPTIC POTENTIAL; PYRAMIDAL NERVE CELL; RAT;

ANIMALS; CEREBRAL CORTEX; ETHANOL; MALE; MEMBRANE POTENTIALS; METHANOL; NEURONS; PLANT EXTRACTS; PLANT ROOTS; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A1; RECEPTORS, GABA-A; SYNAPTIC TRANSMISSION; VALERIAN;

RATTUS; VALERIANA; VALERIANA OFFICINALIS; VALERIANACEAE;

EID: 35348914265     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2197     Document Type: Article

References (24)

1. Abourashed EA, Koetter U, Brattström A. 2004. In vitro binding experiments with a Valerian, Hops and their fixed combination extract (Ze91019) to selected central nervous system receptors. Phytomedicine 11: 633-638.
2. A-receptors. In 18th Congress European Sleep Research Society, Innsbruck, Austria, September 12-16, abstract.
3. Brand A, Vissiennon Z, Eschke D, Nieber K. 2001. Adenosine A(1) and A(3) receptors mediate inhibition of synaptic transmission in rat cortical neurons. Neuropharmacology 40: 85-95.
4. Cherubini E, North RA, Williams JT. 1988. Synaptic potentials in rat locus coeruleus neurones. J Physiol 406: 431-442.
5. Dietz BM, Mahady GB, Pauli GF, Farnsworth NR. 2005. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Brain Res Mol Brain Res 138: 191-197.
6. Dominguez RA, Bravo-Valverde RL, Kaplowitz BR, Cott JM. 2000. Valerian as a hypnotic for Hispanic patients. Cultur Divers Ethnic Minor Psychol 6: 84-92.
7. Füssel A, Wolf A, Brattström A. 2000. Effect of a fixed valerian-hop extract combination (Ze 91019) on sleep polygraphy in patients with non-organic insomnia: a pilot study. Eur J Med Res 5: 385-390.
8. Hentschel S, Lewerenz A, Nieber K. 2003. Activation of A(3) receptors by endogenous adenosine inhibits synaptic transmission during hypoxia in rat cortical neurons. Restor Neurol Neurosci 21: 55-63.
9. Kamlet MJ, Abboud J-LM, Abraham MH, Taft RW. 1983. Linear solvation energy relationships. 23. A comprehensive collection of the solvatochromic parameters π*, α, and β, and some methods for simplifying the generalized solvatochromic equation. J Org Chem 48: 2877-2887.
10. Lacher S, Mayer R, Müller CE. 2005. Interaction of valerian extracts of different polarity with adenosine receptors. Abstract C60/115 DPhG-Tagung 2005 ISBN 3-00-016844-3.
11. Lacher S, Mayer R, Sichardt K, Nieber K, Müller CE. 2007. Interaction of valerian extracts of different polarity with adenosine receptors: Identification of isovaltrate as an inverse agonist at A1 receptors. Biochem Pharmacol 73: 248-258.
12. Müller CE, Schumacher B, Brattström A, Abourashed EA, Koetter U. 2002. Interactions of valerian extracts and a fixed valerian-hop extract combination with adenosine receptors. Life Sci 71: 939-949.
13. Nieber K, Poelchen W, Illes P. 1997. Role of ATP in fast excitatory synaptic potentials in locus coeruleus neurones of the rat. Br J Pharmacol 122: 423-430.
14. Ortiz JG, Nieves-Natal J, Chavez P. 1999. Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release. Neurochem Res 24: 1373-1378.
15. Osmanovic SS, Shefner SA. 1990. Gamma-aminobutyric acid responses in rat locus coeruleus neurones in vitro: a current-clamp and voltage-clamp study. J Physiol 421: 151-170.
16. Rodenbeck A, Simen S, Cohrs S et al. 1998. Veränderte Schlafstadienstruktur als Hinweis auf die GABAerge Wirkung eines Baldrian-Hopfenpräparates bei Patienten mit psychophysiologischer Insomnie. Somnologie 2: 26-31.
17. Santos MS, Ferreira F, Cunha AP, Cavalho AP, Macedo T. 1994a. An aqueous extract of valerian influences the transport of GABA in synaptosomes. Planta Med 60: 278-279.
18. Santos MS, Ferreira F, Faro C et al. 1994b. The amount of GABA present in aqueous extracts of valerian is sufficient to account for [3H]GABA release in synaptosomes. Planta Med 60: 475-476.
19. Santos MS, Ferreira F, Faro C et al. 1994c. Synaptosomal GABA release as influenced by valerian root extract - involvement of the GABA carrier. Arch Int Pharmacodyn Ther 327: 2202-2231.
20. Schellenberg R, Sauer S, Abourashed EA, Koettter U, Brattström A. 2004. The fixed combination of valerian and hops (Ze91019) acts via a central adenosine mechanism. Planta Med 70: 594-597.
21. Schumacher B, Scholle S, Holzl J, Khudeir N, Hess S, Müller CE. 2002. Lignans isolated from valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A(1) adenosine receptors. J Nat Prod 65: 1479-1485.
22. Vissiennon Z, Sichardt K, Koetter U, Brattström A, Nieber K. 2006. Valerian extract Ze 911 inhibits postsynaptic potentials by activation of adenosine A1 receptors in rat cortical neurons. Planta Med 72: 579-583.
23. Yuan CS, Mehendale S, Xiao Y, Aung HH, Xie JT, Ang-Lee MK. 2004. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Anesth Analg 98: 353-358.
24. Ziegler G, Ploch M, Miettinen-Baumann A, Collet W. 2002. Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia - a randomized, double-blind, comparative clinical study. Eur J Med Res 7: 480-486.